Total Payments
$151,054
2024 Payments
$10,692
Companies
52
Transactions
525
Medicare Patients
21,136
Medicare Billing
$2.4M
Payment Breakdown by Category
Other$95,504 (63.2%)
Consulting$28,414 (18.8%)
Travel$15,419 (10.2%)
Food & Beverage$11,434 (7.6%)
Education$283.48 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $93,331 | 46 | 61.8% |
| Consulting Fee | $28,414 | 16 | 18.8% |
| Travel and Lodging | $15,419 | 35 | 10.2% |
| Food and Beverage | $11,434 | 412 | 7.6% |
| Honoraria | $2,000 | 1 | 1.3% |
| Education | $283.48 | 4 | 0.2% |
| Grant | $125.00 | 1 | 0.1% |
| Entertainment | $48.30 | 1 | 0.0% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$151,054
516 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $67,606 | 133 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $22,547 | 71 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $22,227 | 19 | $0 (2024) |
| Janssen Global Services, LLC | $7,575 | 4 | $0 (2020) |
| Sumitomo Pharma America, Inc. | $6,588 | 8 | $0 (2024) |
| Myovant Sciences Inc. | $6,316 | 6 | $0 (2021) |
| Endocare, Inc. | $3,363 | 21 | $0 (2018) |
| Eli Lilly and Company | $2,655 | 4 | $0 (2023) |
| GENZYME CORPORATION | $2,545 | 2 | $0 (2018) |
| Osiris Therapeutics Inc. | $2,093 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,692 | 50 | Janssen Biotech, Inc. ($8,555) |
| 2023 | $19,322 | 55 | Sumitomo Pharma America, Inc. ($6,554) |
| 2022 | $11,298 | 16 | Janssen Biotech, Inc. ($8,537) |
| 2021 | $17,260 | 19 | Janssen Biotech, Inc. ($7,310) |
| 2020 | $19,194 | 43 | Bayer HealthCare Pharmaceuticals Inc. ($11,096) |
| 2019 | $42,381 | 142 | Janssen Biotech, Inc. ($33,714) |
| 2018 | $15,074 | 95 | Janssen Scientific Affairs, LLC ($10,135) |
| 2017 | $15,833 | 105 | Janssen Scientific Affairs, LLC ($9,076) |
All Payment Transactions
525 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $132.78 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $38.40 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $119.77 | General |
| 11/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 11/15/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $24.95 | General |
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diagnostic Imaging | ||||||
| 10/10/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $307.07 | General |
| Category: OS | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $131.70 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Oncology | ||||||
| 08/23/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $89.99 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: HORMONE THERAPY | ||||||
| 07/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Oncology | ||||||
| 06/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: Oncology | ||||||
| 06/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Oncology | ||||||
| 06/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Oncology | ||||||
| 06/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $1.98 | General |
| Category: Oncology | ||||||
| 06/05/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $24.27 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 4,588 | 35,694 | $1.9M | $516,573 |
| 2022 | 41 | 5,279 | 42,897 | $2.3M | $619,115 |
| 2021 | 39 | 5,615 | 50,136 | $2.2M | $639,857 |
| 2020 | 42 | 5,654 | 47,043 | $2.2M | $595,940 |
Total Patients
21,136
Total Services
175,770
Medicare Billing
$2.4M
Procedure Codes
162
All Medicare Procedures & Services
162 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 32 | 4,980 | $224,100 | $92,417 | 41.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 94 | 474 | $412,380 | $62,403 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 524 | 645 | $174,150 | $57,697 | 33.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 148 | 228 | $126,540 | $39,244 | 31.0% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 92 | 17,350 | $121,450 | $38,342 | 31.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 97 | 847 | $71,148 | $36,680 | 51.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 459 | 514 | $97,660 | $31,701 | 32.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 178 | 230 | $82,800 | $29,154 | 35.2% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 93 | 350 | $103,250 | $23,544 | 22.8% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 33 | 5,840 | $58,400 | $18,694 | 32.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 576 | 916 | $64,120 | $16,375 | 25.5% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 190 | 323 | $24,225 | $8,062 | 33.3% |
| 55873 | Destruction of prostate using imaging guidance | Facility | 2023 | 11 | 11 | $98,120 | $6,560 | 6.7% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 22 | 25 | $19,750 | $5,271 | 26.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 25 | 26 | $15,340 | $4,209 | 27.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 124 | 156 | $22,620 | $3,929 | 17.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 36 | $9,684 | $3,608 | 37.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 22 | 29 | $14,455 | $3,285 | 22.7% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2023 | 16 | 17 | $11,475 | $3,225 | 28.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 83 | 108 | $9,072 | $3,069 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $10,660 | $3,013 | 28.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 48 | $6,816 | $2,981 | 43.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 737 | 1,278 | $14,058 | $2,754 | 19.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 24 | 25 | $10,525 | $2,657 | 25.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 277 | 314 | $10,048 | $2,582 | 25.7% |
About Dr. Robert Given, M.D
Dr. Robert Given, M.D is a Urology healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669450680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Given, M.D has received a total of $151,054 in payments from pharmaceutical and medical device companies, with $10,692 received in 2024. These payments were reported across 525 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($93,331).
As a Medicare-enrolled provider, Given has provided services to 21,136 Medicare beneficiaries, totaling 175,770 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 162 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Virginia Beach, VA
- Active Since 01/09/2006
- Last Updated 04/28/2014
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1669450680
Products in Payments
- Erleada (Drug) $50,881
- ERLEADA (Drug) $36,306
- Nubeqa (Drug) $18,264
- ORGOVYX (Drug) $11,605
- DARZALEX (Biological) $9,076
- Xofigo (Drug) $4,283
- Endocare Cryocare System (Medical Supply) $3,329
- JEVTANA (Drug) $2,545
- PROVENGE (Drug) $1,282
- XTANDI (Drug) $891.53
- ZYTIGA (Drug) $444.22
- NANOKNIFE (Device) $307.07
- Axumin (Drug) $246.91
- Xtandi (Drug) $232.93
- XIAFLEX (Biological) $207.54
- Myrbetriq (Drug) $178.91
- Endocare Cryocare System (Device) $165.53
- BOTOX (Biological) $125.00
- Rubraca (Drug) $124.25
- (815) Thiola (Drug) $118.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Virginia Beach
Gregg Eure, M.d, M.D
Urology — Payments: $1.8M
Urology $1.8M
Jessica Delong, M.d, M.D
Urology — Payments: $277,548
Urology $277,548
Michael Williams, M.d, M.D
Urology — Payments: $150,432
Urology $150,432
Kurt Mccammon, M.d, M.D
Urology — Payments: $132,837
Urology $132,837
Ilya Sobol, Md, MD
Urology — Payments: $41,990
Urology $41,990
Ramon Virasoro, M.d, M.D
Urology — Payments: $11,139
Urology $11,139